SEC 13F Intelligence

Armistice Capital, LLC / AMAG

Armistice Capital, LLC’s Amag Pharmaceuticals Inc Position

Does Armistice Capital, LLC own Amag Pharmaceuticals Inc (AMAG)? Not currently — the last reported position was 4.12M shares worth $39M in Q3 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$39M
Q3 2020
Shares
4.12M
% of Portfolio
+1.40%
Quarters Held
3
position exited

Position History AMAG

Reported value by quarter
Q1 ’20: $25MQ1 ’20Q2 ’20: $32MQ2 ’20Q3 ’20: $39MQ3 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20204.12M$39M+1.40%
Q2 20204.12M$32M+1.38%
Q1 20204.12M$25M+1.57%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Armistice Capital, LLC’s full portfolio or all institutional holders of AMAG.